155 related articles for article (PubMed ID: 31659254)
1. ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the NOTCH2 signaling.
Guan C; He L; Chang Z; Gu X; Liang J; Liu R
Oncogene; 2020 Feb; 39(8):1665-1680. PubMed ID: 31659254
[TBL] [Abstract][Full Text] [Related]
2. MTA2 promotes HCC progression through repressing FRMD6, a key upstream component of hippo signaling pathway.
Guan C; Chang Z; Gu X; Liu R
Biochem Biophys Res Commun; 2019 Jul; 515(1):112-118. PubMed ID: 31128910
[TBL] [Abstract][Full Text] [Related]
3. lncAKHE enhances cell growth and migration in hepatocellular carcinoma via activation of NOTCH2 signaling.
Huang G; Jiang H; Lin Y; Wu Y; Cai W; Shi B; Luo Y; Jian Z; Zhou X
Cell Death Dis; 2018 May; 9(5):487. PubMed ID: 29706630
[TBL] [Abstract][Full Text] [Related]
4. CHD4/NuRD complex regulates complement gene expression and correlates with CD8 T cell infiltration in human hepatocellular carcinoma.
Shao S; Cao H; Wang Z; Zhou D; Wu C; Wang S; Xia D; Zhang D
Clin Epigenetics; 2020 Feb; 12(1):31. PubMed ID: 32070428
[TBL] [Abstract][Full Text] [Related]
5. Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.
Gnani D; Romito I; Artuso S; Chierici M; De Stefanis C; Panera N; Crudele A; Ceccarelli S; Carcarino E; D'Oria V; Porru M; Giorda E; Ferrari K; Miele L; Villa E; Balsano C; Pasini D; Furlanello C; Locatelli F; Nobili V; Rota R; Leonetti C; Alisi A
Cell Death Differ; 2017 May; 24(5):889-902. PubMed ID: 28338656
[TBL] [Abstract][Full Text] [Related]
6. SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells.
Yang Y; Qiu R; Zhao S; Shen L; Tang B; Weng Q; Xu Z; Zheng L; Chen W; Shu G; Wang Y; Zhao Z; Chen M; Ji J
BMC Biol; 2022 Dec; 20(1):294. PubMed ID: 36575438
[TBL] [Abstract][Full Text] [Related]
7. NOTCH2 signaling confers immature morphology and aggressiveness in human hepatocellular carcinoma cells.
Hayashi Y; Osanai M; Lee GH
Oncol Rep; 2015 Oct; 34(4):1650-8. PubMed ID: 26252838
[TBL] [Abstract][Full Text] [Related]
8. Notch2 is a crucial regulator of self-renewal and tumorigenicity in human hepatocellular carcinoma cells.
Wu WR; Zhang R; Shi XD; Yi C; Xu LB; Liu C
Oncol Rep; 2016 Jul; 36(1):181-8. PubMed ID: 27221981
[TBL] [Abstract][Full Text] [Related]
9. sZIP, an alternative splice variant of ZIP, antagonizes transcription repression and growth inhibition by ZIP.
Yu W; Li R; Gui B; Shang Y
J Biol Chem; 2010 May; 285(19):14301-7. PubMed ID: 20233718
[TBL] [Abstract][Full Text] [Related]
10. Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis.
Xu X; Liu Z; Zhou L; Xie H; Cheng J; Ling Q; Wang J; Guo H; Wei X; Zheng S
J Exp Clin Cancer Res; 2015 Jan; 34(1):6. PubMed ID: 25609232
[TBL] [Abstract][Full Text] [Related]
11. Pterostilbene inhibits MTA1/HDAC1 complex leading to PTEN acetylation in hepatocellular carcinoma.
Qian YY; Liu ZS; Yan HJ; Yuan YF; Levenson AS; Li K
Biomed Pharmacother; 2018 May; 101():852-859. PubMed ID: 29635894
[TBL] [Abstract][Full Text] [Related]
12. Two distinct Notch signals, Delta-like 4/Notch1 and Jagged-1/Notch2, antagonistically regulate chemical hepatocarcinogenesis in mice.
Nakano Y; Nakao S; Sueoka M; Kasahara D; Tanno Y; Sumiyoshi H; Itoh T; Miyajima A; Hozumi K; Inagaki Y
Commun Biol; 2022 Jan; 5(1):85. PubMed ID: 35064244
[TBL] [Abstract][Full Text] [Related]
13. TIPE‑2 suppresses growth and aggressiveness of hepatocellular carcinoma cells through downregulation of the phosphoinositide 3‑kinase/AKT signaling pathway.
Wang L; Chen C; Feng S; Tian J
Mol Med Rep; 2018 May; 17(5):7017-7026. PubMed ID: 29568863
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
15. BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness.
Kaufmann B; Wang B; Zhong S; Laschinger M; Patil P; Lu M; Assfalg V; Cheng Z; Friess H; Hüser N; von Figura G; Hartmann D
PLoS One; 2017; 12(7):e0180225. PubMed ID: 28700662
[TBL] [Abstract][Full Text] [Related]
16. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.
Zhang B; Zhang Y; Zou X; Chan AW; Zhang R; Lee TK; Liu H; Lau EY; Ho NP; Lai PB; Cheung YS; To KF; Wong HK; Choy KW; Keng VW; Chow LM; Chan KK; Cheng AS; Ko BC
J Pathol; 2017 Dec; 243(4):418-430. PubMed ID: 28862757
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
18. STAT3 and AKT signaling pathways mediate oncogenic role of NRSF in hepatocellular carcinoma.
Ma M; Zhou Y; Sun R; Shi J; Tan Y; Yang H; Zhang M; Shen R; Xu L; Wang Z; Fei J
Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1063-1070. PubMed ID: 32556117
[TBL] [Abstract][Full Text] [Related]
19. Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis.
Guan YF; Huang QL; Ai YL; Chen QT; Zhao WX; Wang XM; Wu Q; Chen HZ
Oncogene; 2020 Mar; 39(11):2408-2423. PubMed ID: 31959898
[TBL] [Abstract][Full Text] [Related]
20. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]